Follows Previously Announced FedRAMP Authorization in Validating DLH’s Commitment to Best-in-Class Information Security and Data Management ServicesATLANTA, April 04, 2022…
Data from 15 presentations will highlight the use of the platform for the treatment of pediatric and adult burn woundsVALENCIA,…
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable…
CareCentrix rebrands palliative offering as CareCentrix Serious Illness Care at HomeHARTFORD, Conn., April 04, 2022 (GLOBE NEWSWIRE) -- CareCentrix, a…
- Webcast will feature Professor Charles Swanton, TRACERx Chief Investigator and Achilles co-founder - - Panel will discuss how TRACERx…
LAS VEGAS, NV, April 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Digipath, Inc. (OTCQB: DIGP) (“Digipath” or the “Company”),…
ALG-097558 demonstrates nanomolar potent antiviral activity and is up to 20-fold more active than nirmatrelvir in cell-based assays against multiple…
Guidelines issued jointly by the American Heart Association, American College of Cardiology and Heart Failure Society of America New guidelines recommend…
NEWARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and…
Certification Gives BioRestorative Therapies Clinical Grade Manufacturing Capabilities MELVILLE, N.Y., April 04, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the…